CSIMarket
 


Biocryst Pharmaceuticals Inc   (BCRX)
Other Ticker:  
 


Biocryst Pharmaceuticals Inc 's EBITDA Margin by quarter

Trends, Rankings, Statistics



BCRX EBITDA Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 17.42 % 14.39 % 25.88 % 37.77 % 68.68 %
Seq. Revenue Change 7.68 % 5.15 % 19.94 % -13.54 % 4.9 %
Revenue In Millions $93.40 $86.74 $82.49 $68.78 $79.55
EBITDA Margin -40.85 % -9.29 % -54.87 % -36.15 % -56.08 %
EBITDA Margin Total Ranking # # # # #
EBITDA In Millions $-38.16 $-8.05 $-45.26 $-24.86 $-44.61
Y / Y EBITDA Change - - - - -
Seq. EBITDA Change - - - - -


Commenting fourth Quarter 2023 EBITDA Margin
Biocryst Pharmaceuticals Inc achived higher Operating Loss of -38 then a $-8.05 millions reported a quarter before.

Observing fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry Biocryst Pharmaceuticals Inc has achieved highest EBITDA Margin. While overall EBITDA Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Operating Margin
BCRX's EBITDA Margin fourth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

EBITDA Margin Statistics
High Average Low
24.19 % 10.99 % 1.52 %
(Jun 30 2015)  




Other EBITDA Margin Profitability Ratios
BCRX's Cumulative EBITDA Margin
Biotechnology & Pharmaceuticals Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
BCRX's EBITDA Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for BCRX's Competitors
EBITDA Margin Profit Margin for Biocryst Pharmaceuticals Inc 's Suppliers
EBITDA Margin Profit Margin for BCRX's Customers

You may also want to know
BCRX's Annual Growth Rates BCRX's Profitability Ratios BCRX's Asset Turnover Ratio BCRX's Dividend Growth
BCRX's Roe BCRX's Valuation Ratios BCRX's Financial Strength Ratios BCRX's EBITDA Growth
BCRX's Roa BCRX's Inventory Turnover Ratio BCRX's Growth Rates BCRX's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry EBITDA MarginDec 31 2023 MRQ EBITDADec 31 2023 MRQ Revenue




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com